IB Communications

🌿 Something for all you plant lovers out there... Charles Legg from Zea Biosciences talks to IBTV about how they're using plants to produce biologics and vaccines, what food and medicine production might look like in space, and the projects the team has been working on in the background. 👀 Watch the full interview, here: https://lnkd.in/dQqWWaFJ #BIO24 #BIO2024 #Bullpen Bullpen #PlantPower

Chandima Bandara Bandaranayaka M speaks to IBTV about the gaps in the pharmaceutical drug development process identified by Precision Quantomics, particularly considering marginalized populations. 👀 Watch the full interview as Chandima explains how Precision Quantomics is looking to address these issues with proteomics, data and modelling, ultimately for better and faster drug candidate development: https://lnkd.in/dCCK3yga #BIO24 #BIO2024 #Bullpen Bullpen #DrugDevelopment

Tamika Jackson (Successful Strategies for Life Sciences) spoke to IBTV about the principles behind The Beautiful Way Foundation, including the disparities in the representation of black and hispanic communities in clinical trials, how addressing obstacles can encourage participation in trials, and how this approach could lead to better health outcomes. 👀 Watch the full video to find out more about The Beautiful Way Foundation, as well as Tamika's role as DEI Director with Bullpen: https://lnkd.in/dja5YNdc #Bullpen #BIO24 #BIO2024 #DEI #ClinicalTrials #Representation

In this interview, Matt Zubyk explains how the team at Petalouda Therapeutics is working to address chronic pain with RNA therapeutics, drawing from his own experience as a chronic pain patient with a Hodgkin lymphoma diagnosis. Matt goes on to discuss what the future looks like for the company, with support from the Bullpen community. 👀 Watch the full interview, here: https://lnkd.in/enc48HHT #RNA #Investment #Bullpen #PainManagement #BIO24 #BIO2024 IBTV

Back in the #BIO2024 Bullpen, Kaitlin Roberson describes the disparity between treating the pain condition vs the psychological drivers of pain for patients, how Cacti is looking to address this issue, and how the Bullpen event is supporting the all-important early stage investment conversations needed to drive innovative start-ups forward. 👀 Watch the full interview to find out more about Cacti, this year's seed round and the Bullpen event, here: https://lnkd.in/eQdP64vc #BIO24 #Bullpen #PainManagement #PainTreatment #Investment

In this IBTV interview, Jim Pollock, CEO of LumenAstra, describes the applications for a novel sensor technology for monitoring internal body temperature from the surface, including in the operating theater, in the ICU and in the field with the military. 👀 Watch the full interview to learn more about the tech, what the company is looking for in order to advance the applications of the technology to make the most impact, and how organizations like Bullpen support this vision: https://lnkd.in/eMDhCzTt #Bullpen #BIO24 #BIO2024 #Investment #Technology #HealthTech

At Bullpen's #BIO24 event, Jaynee Sasso, MBA, founding member of Bullpen, talks to IBTV about how Senior Runs benefits the senior community, how other communities within healthcare may benefit from this model, and what the company needs in order to expand the service. Jaynee closes by reflecting on the impact of events hosted by organizations like Bullpen, avoiding situations where you're "networking for the sake of networking"... 👀 Watch the full interview, here: https://lnkd.in/eWj9yGK7 #BIO2024 #Bullpen #SeniorHealth #CommunityHealth #Investment

⏰ Starting soon!! Michelle Boxall (IB Communications), Priya Baraniak, Ph.D. (OrganaBio), Doris A. Taylor (Organamet Bio Inc.) and Alyssa Waid (Thermo Fisher Scientific) are about to kick off their #WIATGlobal session on ‘Shattering Stigma: Women’s Health ‘Taboos in Cell and Gene Therapy’.   🖥️ It’s not too late to join! Register now – FOR FREE – to join the session in 30 minutes time: https://bit.ly/4cTuoVs   #WomenInSTEM #WomenInCGT #WomensHealth #WIAT #WIATGlobal Phacilitate

On the show floor at #BIO24, Stuart Gibb, Ph.D (Terumo Blood and Cell Technologies) speaks to IBTV about how cell therapy is meeting patient need, and how device manufacturers can meet the needs and expectations of developers. 🎥 Watch the full interview, below 👇 https://lnkd.in/g6EmTGSc #BIO2024 #CellTherapy #PatientCentricity

Extending a big thank you to Priya Baraniak, Ph.D. for the invitation. I’m usually orchestrating the speakers, so I a little outside my comfort zone. But couldn’t say no to Priya or the topic! Looking forward to breaking through glass ceilings and shattering stigmas!